Ramesh Kumar - 18 Jul 2022 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role: Director
Signature: /s/ Ramesh Kumar by Shankar Musunuri, his attorney-in-fact
Issuer symbol: OCGN
Transactions as of: 18 Jul 2022
Net transactions value: -$15,450
Form type: 4
Filing time: 20 Jul 2022, 16:19:18 UTC
Previous filing: 08 Jun 2022
Next filing: 07 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCGN	Common Stock	Options Exercise	$3,825	+7,500		$0.5100	7,500	18 Jul 2022	Direct
transaction	OCGN	Common Stock	Sale	$19,275	-7,500	-100%	$2.57^*	0	18 Jul 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCGN	Option (Right to Buy)	Options Exercise	$0	+7,500	+500%	$0.000000	9,000	18 Jul 2022	Common Stock	7,500	$0.5100	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.56 to $2.61. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3	The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates.